alexa Gavin P Robertson | OMICS International
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Gavin P Robertson

The Pennsylvania State University College of Medicine, USA
Biography

Gavin P. Robertson, Ph.D. is Professor of Pharmacology, Pathology, Dermatology and Surgery at Penn State University, Director, Penn State Melanoma Center, and Director, Foreman Foundation Melanoma Research Laboratory in the Department of Pharmacology and Penn State Cancer Institute. His research focuses on malignant melanoma; the most deadly form of skin cancer, with the goal of unraveling the biology and signaling pathways involved in melanoma tumor development, and in developing the next generation of therapeutic agents to treat this disease. The discovery of Akt3 involvement in ~70% of human melanomas led to the development of ISC-4, which targets Akt3 signaling. Nanotechnology and bioengineering are enabling the use of nanoliposomes and ultrasound that deliver therapeutic products into melanoma cells, leading to the development of Nanolipolee-007. His translational research program is focused on developing better therapeutics based on the biology of the disease. He holds a Ph.D., University of California, Riverside, and completed his Postdoctoral Training at the Ludwig Institute for Cancer Research in San Diego.

Research Interest

Drug Resistance,Bone Marrow Cancer,Cancer Therapies, Nanotechnology, Nanobiotechnology, Nanocomposites, Nanobiopharmaceutics, Nanoelectronics, Nanomedicine, Nanotoxicology

Publications

Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy

Raghavendra Gowda, Nathan R Jones, Shubhadeep Banerjee and Gavin P Robertson

Review Article: J Nanomed Nanotechnol 2013, 4:184

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version